Shawn’s Trade Idea: Lifting stops on NOVO Nordisk (NOVO US) to $US59.50

We are lifting our stops on NOVO Nordisk (NOVO US) to $US59.50 as the $US60 resistance level becomes support. This is a technically driven tweak as the upside momentum starts to wane ahead of its earnings report on the 4th of February which will be pivotal to the stocks short term performance.

• We continue to target the $US80 area for NOVO through 2026.